ACCORD HEALTHCARE, INC. recalls
Every recall we track for ACCORD HEALTHCARE, INC. — 106 in all, from 2016–2026 — plus the complaints and injury reports the public filed about them. 4 are rated “stop using now”.
Recalls per year, by danger level
Recalls from ACCORD HEALTHCARE, INC. doubled in 2025 (12, up from 6 in 2024). 4% rated “stop using now”.
All FDA recall records for ACCORD HEALTHCARE, INC. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 1 | 0 | 1 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 0 | 0 | 1 |
| 2023 | 2 | 1 | 8 | 60 | 71 |
| 2024 | 1 | 1 | 3 | 1 | 6 |
| 2025 | 0 | 0 | 12 | 0 | 12 |
| 2026 (to date) | 0 | 0 | 13 | 0 | 13 |
ACCORD HEALTHCARE, INC. recalls before 2017
Recalls on record by year.
Most common reasons for ACCORD HEALTHCARE, INC. recalls
What to do if you have a recalled ACCORD HEALTHCARE, INC. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All ACCORD HEALTHCARE, INC. recalls
17 shown- Lower riskDrug
ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b)
Accord Healthcare recalls 90-count and 1000-count levothyroxine tablets with subpotent drug levels. These tablets may not provide the intended thyroid hormone dose. Consumers should contact the manufacturer for details.
Accord HealthcareAug 6, 2026 - Lower riskDrug
ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare,
Accord Healthcare recalls 90-tablet Levothyroxine Sodium 300 mcg bottles due to subpotent drug content. This may not provide proper thyroid hormone levels. Consumers should contact pharmacy for guidance.
Accord HealthcareJun 8, 2026 - Lower riskDrug
ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord
Accord Healthcare recalls Levothyroxine Sodium Tablets (88 mcg) due to subpotent content. This may lead to insufficient thyroid hormone levels. Consumers should contact the manufacturer for details.
Accord HealthcareSep 16, 2025 - Lower riskDrug
ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare,
Accord Healthcare recalls 1000-count levothyroxine tablets due to assay below approved levels. This may result in insufficient thyroid hormone delivery. Consumers should contact the manufacturer for details.
Accord HealthcareJun 20, 2025 - Lower riskDrug
ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc.,
Accord Healthcare recalls 1000-bottle supply of Levothyroxine Sodium Tablets (88 mcg) due to subpotent levels. This may not provide adequate thyroid hormone. No remedy specified in recall notice.
Accord HealthcareApr 10, 2025 - Lower riskDrug
ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare,
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug levels. This may not provide proper thyroid hormone treatment. Consumers should contact the manufacturer for details.
Accord HealthcareNov 8, 2024 - Lower riskDrug
ACCORD HEALTHCARE, INC. recalls Cinacalcet Tablets, 90 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-442-10, b) 90 Tablets per bottle, NDC:
Accord Healthcare recalls Cinacalcet 90mg tablets (NDC 16729-442-10 and 16729-442-15) due to potential nitrosamine impurities exceeding safe levels. Consumers should contact the manufacturer for details.
Accord HealthcareOct 10, 2024 - Stop using nowDrug
ACCORD HEALTHCARE, INC. recalls Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for:
Accord Healthcare recalls cisplatin injection vials due to failed impurities and degradation specifications. This could cause serious injury if used improperly. Patients should contact their doctor for guidance.
Accord HealthcareOct 1, 2024 - Use cautionDrug
Accord Healthcare, Inc. recalls Dodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, Manufactured for: Accord
Accord Healthcare recalls Dodex Injectable due to subpotent drug results. Check lot numbers R2200834, R2201144 and expiration dates before use.
Accord HealthcareJun 18, 2024 - Stop using nowDrug
Accord Healthcare, Inc. recalls Bivalirudin for Injection 250 mg, 10 Single-Dose Vials, Rx Only, Manufactured for: Accord Healthcare, Inc. Durham, NC
Accord Healthcare recalls 10 vials of Bivalirudin 250mg injection due to fiber particles. This may cause serious injury if injected. Stop using and contact for return.
Accord HealthcareJul 3, 2023 - Use cautionDrug
Accord Healthcare, Inc. recalls Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or
Accord Healthcare recalls Dodex Injectable Cyanocobalamin Injection due to sub-potent assay results. Check your lot number and expiration date.
DodexMar 29, 2023 - UnratedDrug
Accord Healthcare, Inc. recalls Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC
Accord Healthcare recalls Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottles manufactured for FDA compliance issues. Recalled batches expire through May 2025.
Accord HealthcareFeb 7, 2023 - Lower riskDrug
Accord Healthcare, Inc. recalls Allopurinol Tablets USP, 100 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC
Accord Healthcare recalls 100-count Allopurinol tablets (100 mg) due to small green plastic piece in some tablets. This may cause injury if swallowed. Return to pharmacy for replacement.
Accord HealthcareJan 12, 2023 - Stop using nowDrug
Accord Healthcare, Inc. recalls Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC
Accord Healthcare recalls specific lots of Daptomycin for Injection because cartons labeled as 350 mg/vial contained 500 mg/vials.
Accord HealthcareNov 29, 2022 - Lower riskDrug
Accord Healthcare, Inc. recalls Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord
Accord Healthcare recalls 25x2mL Glycopyrrolate injection vials due to label mix-up with 1mL vials. Correctly labeled vials were packaged into blister strips intended for 1mL vials.
Accord HealthcareJan 28, 2021 - Lower riskDrug
Accord Healthcare, Inc. recalls Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham,
Accord Healthcare recalls 100-count Hydrochlorothiazide tablets after customer complaints of containing Spironolactone instead. This mix-up could lead to incorrect medication use. Check your prescription bottle for the label and contact your pharmacy.
Accord HealthcareAug 21, 2018 - Use cautionDrug
Accord Healthcare, Inc. recalls Lisinopril tablets, 5 mg, 1000-count bottle, Rx only, Manufactured for Accord Healthcare, Inc., Durham, NC 27703, NDC
Accord Healthcare recalls specific lots of Lisinopril 5 mg tablets because they lack the required break line. Check your bottle's lot number and expiration date.
Accord HealthcareDec 20, 2016
ACCORD HEALTHCARE, INC. recall questions
How many recalls has ACCORD HEALTHCARE, INC. had?
106 recalls from ACCORD HEALTHCARE, INC. are on record with U.S. safety agencies, from 2016–2026.
What is the most recent ACCORD HEALTHCARE, INC. recall?
ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b), dated Aug 6, 2026. Every ACCORD HEALTHCARE, INC. recall is listed on this page, newest first.
Why are ACCORD HEALTHCARE, INC. products recalled?
The most common reasons on record: CGMP Deviations: recalling drug products following an FDA inspection. (67); Subpotent Drug (13); Subpotent Drug: Assay below the approved specification (7); Subpotent (4).
What should I do if I have a recalled ACCORD HEALTHCARE, INC. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new ACCORD HEALTHCARE, INC. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.